HNN3.0
Register
Register
Register

Project cooperationUpdated on 25 January 2026

CUTIVAX

Head of Project & IP Management at Bogazici University Center for Targeted Therapy Technologies

İstanbul, Türkiye

About

CUTIVAX PLATFORM

Tumor tissue collected during surgery or biopsy.

Cells inactivated with Far-UVC turn into immunogenic “ghosts”.

Implanted subcutaneously or in a surgical lodge near lymphatic regions.

Immune cells infiltrate & trigger local and systemic immunity.

Topic

  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
  • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies

Type

  • Consortium/Coordinator seeks Partners

Organisation

Similar opportunities